Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00574028 · ClinicalTrials.gov registry record
Inflammatory Bowel Disease Research Registry
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 138
- Enrollment target
NCT00574028: Completed study, sponsored by University of California, Irvine.
NCT00574028 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 138 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00574028 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 138 participants
- Enrollment target
Study Summary
The objective and aims of this study is to develop The University of California Irvine Medical Center Inflammatory Bowel Disease Research Registry for the purpose of: 1. Performance of retrospective studies on inflammatory bowel disease to assess disease outcomes and response to therapy. 2. Obtaining permission from the Research Registry participants to be contacted by members of The University of California Irvine Medical Center Inflammatory Bowel Disease Research Center to identify patients that may be eligible for participation in future research studies. 3. Performance of studies to quantify disease phenotypes and treatment patterns.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2007-08 |
| Est. Completion | 2014-04 |
What the finished NCT00574028 record still lists
NCT00574028 is an observational study that tracks outcomes without assigning an intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00574028 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00574028 about?
NCT00574028 is a clinical study titled "Inflammatory Bowel Disease Research Registry". The objective and aims of this study is to develop The University of California Irvine Medical Center Inflammatory Bowel Disease Research Registry for the purpose of: 1. Performance of retrospective studies on inflammatory bowel disease to assess disease outcomes and response to therapy. 2. Obtaini...
What is the current status of trial NCT00574028?
This trial is currently completed. The enrollment target is 138 participants. The study started on 2007-08. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT00574028?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia